The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news ...
The independent panel casted doubt on MDMA being a safe and effective treatment. A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of ...
A recent study conducted in Norway suggests that MDMA-assisted therapy may provide lasting relief for individuals suffering from major depressive disorder. The findings indicate that the clinical ...
The Food and Drug Administration on Friday rejected a California drug company's request to market the psychedelic drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder ...
A 41-year-old woman in a case study reported remarkable improvements of longhauler’s symptoms after taking psilocybin and MDMA-assisted therapy sessions. A case report, “Long-COVID symptoms improved ...
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this ...
Share on Pinterest A key FDA panel voted down approving MDMA-assisted therapy to treat PTSD. pixdeluxe/Getty Images An expert panel of the Food and Drug Administration reviewed two studies on ...
Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to ...
A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results